Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Genentech

Genentech?uq=3Oe4kK1Z
1976 FOUNDED
M&A STATUS
10K-15K EMPLOYEES
M&A LATEST DEAL TYPE
6 FINANCING ROUNDS
29 INVESTMENTS
Description

Discoverer, developer and manufacturer of pharmaceutical products focusing on immunology and oncology medical fields. The company offers pharmaceutical products that have applications in ophthalmology, metabolism, and virology fields. It's products include Lucentis, a ranibizumab injection for treatment of diabetic macular edema, and ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 1 DNA Way Mailstop 258A
  • South San Francisco, CA 94080
  • United States

+1 (650) 000-0000

Genentech Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Genentech‘s full profile, request access.

Request full access to PitchBook

Genentech Investments & Acquisitions (29)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 27-Nov-2018 000000000000000000 Drug Discovery 00000 00000
0000000000 13-May-2016 00000 00000 00 00000 Biotechnology
0000000 0000000000 27-Aug-2014 000000000000000000 00.000 Drug Discovery 0000000 00000000 00.0
0000000000000 0000 05-Aug-2014 00000 00000 00 000 Biotechnology
Immunogen 20-Sep-2013 PIPE 000.00 Biotechnology 000 00000
To view this company’s complete investment and acquisition history, request access »

Genentech Exits (16)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000000 0000 05-Aug-2014 00000 00000 00 000 Completed
  • 5 buyers
0000000000000 0000 01-Jan-2012 00000 00000 00 0000 Completed
  • 000000000
000000 30-Oct-2007 00000 00000 00 0000 Completed
  • 9 buyers
00000 000000000000 10-May-2007 00000 00000 00 000.00 Completed
  • 6 buyers
Proacta 07-Feb-2007 Early Stage VC 000.00 Completed
  • 8 buyers
To view this company’s complete exits history, request access »

Genentech Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Genentech‘s full profile, request access.

Request full access to PitchBook

Genentech Executive Team (34)

Name Title Board
Seat
Contact
Info
Bill Anderson Board of Director, Region Head, North America & Chief Executive Officer
Ed Harrington Chief Financial Officer & Head of Pharma Finance North America
Frederick Kentz III Senior Vice President, Secretary, Chief Compliance Officer and Head of Legal Affairs, North America
Abhi Pandey Pipeline & Portfolio Planning
Gary Otake Principal Engineer of Device Development

18 Former Executives

You’re viewing 5 of 34 executives. Get the full list »

Genentech Board Members (6)

Name Representing Role Since Contact
Info
0000 00000000 Genentech Board of Director, Region Head, North America & Chief Executive Officer 000 0000
000000 0'000 Self Board Member 000 0000

4 Former Board Members

You’re viewing 2 of 6 board members. Get the full list »